

21 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/21/3170125/0/en/Ardelyx-Announces-Four-Abstracts-Accepted-for-Poster-Presentations-at-the-American-Society-of-Nephrology-s-Kidney-Week.html

06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075025/0/en/Ardelyx-Presents-Data-Supporting-IBSRELA-tenapanor-at-Digestive-Disease-Week-2025-Conference.html

10 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/10/3059694/0/en/Post-Hoc-Analysis-of-the-OPTIMIZE-Study-Supporting-XPHOZAH-tenapanor-to-be-Presented-at-the-National-Kidney-Foundation-Spring-Clinical-Meetings.html

31 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/31/3052751/0/en/Ardelyx-to-Share-a-Post-Hoc-Analysis-of-the-OPTIMIZE-Study-Supporting-XPHOZAH-tenapanor-at-the-National-Kidney-Foundation-Spring-Clinical-Meetings.html

26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032784/0/en/Tenapanor-Approved-in-China-for-Hyperphosphatemia.html

24 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/10/24/2969087/0/en/Ardelyx-Shares-Additional-Data-Supporting-First-In-Class-XPHOZAH-tenapanor-at-the-American-Society-of-Nephrology-s-Kidney-Week.html